Recalls and Safety Alerts: Warning on Intracranial Hemorrhage with Aptivus
Published by Food and Drug Adminstration (FDA): Patient Safety September 30th, 2006 in Patient Safety, Regulatory AffairsBoehringer Ingelheim is alerting healthcare professionals about a new black box warning for the company’s antiretroviral drug Aptivus (tipranavir). The warning describes reports of both fatal and non-fatal intracranial hemorrhage (ICH) in patients r…